Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Pharma
With strong data, Lilly plots filings for weekly insulin asset
With detailed readouts from a suite of late-stage trials, Eli Lilly is heading to regulators with its once-a-week insulin asset efsitora alfa.
Fraiser Kansteiner
Jun 23, 2025 10:16am
AZ touts Ultomiris results in post-transplant complication trial
Jun 16, 2025 10:32am
InflaRx scraps vilobelimab study in rare skin disorder
May 28, 2025 9:55am
Gilead's Trodelvy chalks up another phase 3 breast cancer win
May 23, 2025 10:10am
Novo heads to regulators after Sogroya posts positive results
May 13, 2025 9:50am
Summit stock falls as Akeso shares bispecific OS data vs. Keytruda
Apr 25, 2025 4:02pm
